Total operating expenses for the fourth quarter of 2024 were $287 million, including non-cash stock-based compensation of $40 ...
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
As Swansea City get set to face Stoke City, we take a closer look at the Potters. Having initially been founded in 1863 as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback